SCHEMBL4453829

SCHEMBL4453829

COc1ccc(-c2ccc(CC=O)cc2)cc1CCc1ccccc1

nearest known ligand 0.56

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
ABCB1 P08183 2/20 0.47
ABCG2 Q9UNQ0 1/20 0.47
PDE4A P27815 2/20 0.44
PDE4B Q07343 2/20 0.44
PDE4C Q08493 2/20 0.44
PDE4D Q08499 2/20 0.44
SLC2A1 P11166 1/20 0.44
CRHBP P24387 1/20 0.42
PPARG P37231 1/20 0.42
PPARD Q03181 1/20 0.42
PPARA Q07869 1/20 0.42
CRHR2 Q13324 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4085503 0.87 ABCB1 (0.54) ABCB1ABCG2PDE4APDE4BPDE4C
SCHEMBL4457870 0.83 HSD17B1 (0.48) PPARGPPARDPPARA
SCHEMBL4096434 0.80 PDE4A (0.55) PDE4APDE4BPDE4CPDE4D
SCHEMBL13144543 0.77 NPSR1 (0.59) ABCB1
SCHEMBL10627409 0.75 HTR1A (0.43) ABCB1ABCG2PDE4APDE4BPDE4C
SCHEMBL22265145 0.73 MAOB (0.52)
SCHEMBL31555136 0.72 ABCB1 (0.58) ABCB1ABCG2
SCHEMBL34463070 0.72 TAAR1 (0.61)
SCHEMBL28131611 0.72 ALOX5 (0.54) ABCB1ABCG2
Phenylacetaldehyde SCHEMBL14690605 0.72 MAOB (0.55)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2013176-A2 DIARYL COMPOUNDS AS NON-STEROIDAL INHIBITORS OF 17-BETA HYDROXYSTEROID DEHYDROGENASE AND/OR STEROID SULPHATASE FOR THE TREATMENT OF OESTROGEN-RELATED DISEASES SUCH AS HORMONE DEPENDENT BREAST CANCER Sterix Limited (GB) 2009-01-14 EP disclosed
WO-2007096647-A2 DIARYL COMPOUNDS AS NON-STEROIDAL INHIBITORS OF 17-BETA HYDROXYSTEROID DEHYDROGENASE AND/OR STEROID SULPHATASE FOR THE TREATMENT OF OESTROGEN-RELATED DISEASES SUCH AS HORMONE DEPENDENT BREAST CANCER STERIX LIMITED (GB) 2007-08-30 WO disclosed